Key result
This review highlights the ongoing challenges in defining, diagnosing, and managing hypertension in patients with chronic kidney disease and end-stage renal disease.
This review highlights the ongoing challenges in defining, diagnosing, and managing hypertension in patients with CKD and ESRD.
Hypertension is very prevalent among patients with chronic kidney disease (CKD) and end-stage kidney disease (ESRD). However, there are still several unsolved issues pertaining to the definition, variability, diagnosis and management of hypertension in these patients. This manuscript critically reviews the current challenges in clinical practice in defining, diagnosing and treating hypertension in CKD and ESRD patients. Moreover, the manuscript reviews the pharmacokinetics, pharmacodynamics and safety of most anti-hypertensive drugs used in the management of these patients.
No takes yet. Share an insight, caveat, or question.
Campese et al. (2016) conducted a review in Hypertension in chronic kidney disease (CKD) and end-stage kidney disease (ESRD). Anti-hypertensive drugs was evaluated. This review highlights the ongoing challenges in defining, diagnosing, and managing hypertension in patients with chronic kidney disease and end-stage renal disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: